A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture

11.5K views

⸱

DOI:

10.3791/61392

⸱

June 23rd, 2020

 ,  ,  ,  ,  ,  ,  , 

Corresponding Authors: Anton Wellstein <wellstea@georgetown.edu>

In This Article

Summary

The presented approach simultaneously evaluates cancer cell invasion in 3D spheroid assays and T-cell cytotoxicity. Spheroids are generated in a scaffold-free agarose multi-microwell cast. Co-culture and embedding in type I collagen matrix are performed within the same device which allows to monitor cancer cell invasion and T-cell mediated cytotoxicity.

Abstract

Significant progress has been made in treating cancer with immunotherapy, although a large number of cancers remain resistant to treatment. A limited number of assays allow for direct monitoring and mechanistic insights into the interactions between tumor and immune cells, amongst which, T-cells play a significant role in executing the cytotoxic response of the adaptive immune system to cancer cells. Most assays are based on two-dimensional (2D) co-culture of cells due to the relative ease of use but with limited representation of the invasive growth phenotype, one of the hallmarks of cancer cells. Current three-dimensional (3D) co-culture systems either require special equipment or separate monitoring for invasion of co-cultured cancer cells and interacting T-cells.

Here we describe an approach to simultaneously monitor the invasive behavior in 3D of cancer cell spheroids and T-cell cytotoxicity in co-culture. Spheroid formation is driven by enhanced cell-cell interactions in scaffold-free agarose microwell casts with U-shaped bottoms. Both T-cell co-culture and cancer cell invasion into type I collagen matrix are performed within the microwells of the agarose casts without the need to transfer the cells, thus maintaining an intact 3D co-culture system throughout the assay. The collagen matrix can be separated from the agarose cast, allowing for immunofluorescence (IF) staining and for confocal imaging of cells. Also, cells can be isolated for further growth or subjected to analyses such as for gene expression or fluorescence activated cell sorting (FACS). Finally, the 3D co-culture can be analyzed by immunohistochemistry (IHC) after embedding and sectioning. Possible modifications of the assay include altered compositions of the extracellular matrix (ECM) as well as the inclusion of different stromal or immune cells with the cancer cells.

Introduction

Despite significant improvements in cancer immunotherapy over the past decade, our mechanistic understanding of sensitivity and resistance to treatments are still fairly poor1. It is well-established that tumors display substantial heterogeneity, and that the dynamic interactions of the tumor cells with their microenvironment as well as with the immune cells, impact tumor cell death, invasive behavior and response to treatments that include immunotherapy1,2,3. As one arm of the adaptive immune system, T-cells execute cell-specific cytotoxicity. The ana....

Access restricted. Please log in or start a trial to view this content.

Protocol

A list and explanation of some frequently used words throughout the protocol can be found in Supplementary File 1.

1. Generation of spheroids

  1. Prepare and autoclave 2% agarose in 1x PBS (e.g., 1 g agarose in 50 mL of 1x PBS) and autoclave 35- and 81-microwell rubber molds.
    CAUTION: Avoid using low-melting agarose for generating the agarose casts for IHC processing.
  2. Prepare agarose casts
    NOTE: 35-microwell casts are used for invasion, immunofluorescence (IF) and cell isolation assays. 81-microwell casts are used for cytotoxicity, immunohistochemistry (IHC), cell isolation and RNA extraction....

Access restricted. Please log in or start a trial to view this content.

Results

The 3D co-culture model allows for different assays shown in Figure 1A, which can be combined or modified as needed. In our established experimental setup, tumor and T-cells are co-cultured for 2 days followed by initiation of the invasion assay for selection of invasive and/or resistant tumor cells (Figure 1B). On day 4 the quantitation of invasion is performed and “survivor” cells are isolated from the collagen matrix or directly processed for RNA

Access restricted. Please log in or start a trial to view this content.

Discussion

The method presented here describes 3D tumor spheroid generation, which allows co-culture with T-cells, cell-based functional and molecular assays, as well as a variety of monitoring and analysis possibilities using a single device. The major advantage of our approach is that it does not necessitate transfer of the 3D culture to a separate assay and maintains the integrity of the 3D culture throughout the assays.

The workflow presented here can be modified as needed. The incubation times for s.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

We thank Virginie Ory, PhD for helpful discussions and advice on the approach of the 3D co-culture model. We also thank Elizabeth Jones for excellent technical assistance with the IHC sectioning. This study was supported by grants from the DFG (Deutsche Forschungsgemeinschaft) to YL (LI 2547/4-1) and the National Institutes of Health to AW (R01 CA231291), to ATR (R01 CA205632), to GWP (R01 CA218670), and the Core Grant of the Cancer Center (P30 CA51008).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
3D Petri DishesMicrotissues IncZ764019 & Z764051referred to as "rubber molds" in the protocols; 81-microwell & 35-microwell molds
8-well Chamber SlidesLab-Tek154534
Agarose Type I, low EEOSigma-AldrichA6013
anti-rabbit-HRP conjugated secondary antibodyAgilentK4003ready to use
Collagen Type I, Rat Tail, 100 mgMillipore08-115
Collagenase Type 4, 1 gWorthingtonLS004188
DMEM, fetal bovine serumThermoFisher11965092, 16000044referred to as "cell culture medium" in the protocols
Harris hematoxylinThermoFisherSH30-500D
HistoGelThermoFisherHG-4000-012referred to as "Hydroxyethyl agarose processing gel" in the protocols
HoechstLife TechnologiesH13991/1000 dilution
Phalloidin 546Invitrogen4866241/200 dilution
rabbit anti-CD8 antibodyCell Signaling989411/25 dilution
rat anti-keratin 8DSHBTROMA-I AB_5318261/500 dilution
RNeasy Mini KitQiagen74104referred to as "RNA extraction kit" in the protocols
RPMIThermoFisher11875093for T-cell culture medium
Triton X-100BioRad1610407referred to as "Octoxynol" in the protocols
TrizolThermoFisher15596026referred to as "guanidinium thiocyanate with phenol" in the protocols
Tween 20Sigma-AldrichP1379referred to as "polysorbate 20" in the protocols
TypLEThermoFisher12604013referred to as "cell dissociation enzymes solution" in the protocols

References

  1. Chen, D. S., Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature. 541 (7637), 321-330 (2017).
  2. Sharma, P., Allison, J. P. Dissecting the mechanisms of immune checkpoint therapy. Nature Reviews Immunology. 20 (2), 75-76 (2020).
  3. Blom....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

3D Spheroid Co-CultureAgarose Microwell CastsType I Collagen MatrixImmunofluorescence StainingConfocal MicroscopyFluorescence Activated Cell SortingImmunohistochemistry StainingExtracellular Matrix Modification